Clinical and demographic characteristics of patients (pts) treated with vemurafenib in real-world setting

被引：0
|
作者：
Sadetsky, N. [1 ]
Corvino, F. [2 ]
Surinach, A. [2 ]
Goodman, G. [1 ]
机构：
[1] Genentech Inc, San Francisco, CA 94080 USA
[2] Genesis Res LLC, Hoboken, NJ USA
来源：
MELANOMA RESEARCH | 2016年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P062
引用
下载
收藏
页码：E42 / E42
页数：1
相关论文
共 50 条
  • [41] QUALITY OF LIFE OF PATIENTS TREATED FOR MULTIPLE MYELOMA (MM) IN FRANCE IN A REAL-WORLD SETTING
    Despiegel, N.
    Touboul, C.
    Flinois, A.
    Saba, G.
    Gonzalez-McQuire, S.
    Suzan, F.
    Blachier-Poisson, C.
    Guilhaume, C.
    VALUE IN HEALTH, 2016, 19 (07) : A383 - A383
  • [42] PREDICTORS OF RESPONSE IN PATIENTS WITH ANKYLOSING SPONDYLITIS TREATED WITH INFLIXIMAB OR GOLIMUMAB IN A REAL-WORLD SETTING
    Bessette, L.
    Kapur, S.
    Zummer, M.
    Starr, M.
    Choquette, D.
    Sheriff, M.
    Olszynski, W.
    Rampakakis, E.
    Psaradellis, E.
    Osborne, B.
    Maslova, K.
    Nantel, F.
    Lehman, A. J.
    Tkaczyk, C. M.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1131 - 1131
  • [43] Weight loss response in patients with obesity treated with injectable semaglutide in a real-world setting
    Khaled Alabduljabbar
    Moath Alsaqaaby
    Karl J. Neff
    Michael Crotty
    Carel W. le Roux
    Endocrine, 2024, 83 : 392 - 398
  • [44] Weight loss response in patients with obesity treated with injectable semaglutide in a real-world setting
    Alabduljabbar, Khaled
    Alsaqaaby, Moath
    Neff, Karl J.
    Crotty, Michael
    le Roux, Carel W.
    ENDOCRINE, 2024, 83 (02) : 392 - 398
  • [45] Prevalence, Characteristics, and Clinical Burden among Patients with Overweight or Obesity and Established ASCVD in a US Real-World Setting
    Michalak, Wojciech
    Boame, Nana
    Zhao, Xin
    Lamarre, Neil
    Rava, Andrew
    Doan, Quan V.
    Faurby, Mads
    Hartaigh, Briain O.
    Fabricatore, Anthony
    Zhao, Zhenxiang
    DIABETES, 2024, 73
  • [46] Real-world evidence and clinical characteristics in patients (pts) with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICI)
    Iranzo, P.
    Callejo, A.
    Marmolejo, D.
    Assaf, J. D.
    Pardo, N.
    Navarro, A.
    Martinez-Marti, A.
    Cedres, S.
    Diaz Mejia, N. M.
    Carbonell, C.
    Amat, R.
    Frigola, J.
    Felip, E.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S767 - S767
  • [47] Characteristics and short-term outcomes of patients with type 2 diabetes mellitus treated with canagliflozin in a real-world setting
    Buysman, Erin K.
    Chow, Wing
    Henk, Henry J.
    Rupnow, Marcia F. T.
    CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (01) : 137 - 143
  • [48] Real-world behavioral restrictional practices of cancer patients (pts)
    Shachar, Eliya
    Moisa, Noy
    Peleg-Hasson, Shira
    Safra, Tamar
    Wolf, Ido
    Vorobiof, Daniel A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [49] Real-World Assessment of Baseline Demographic and Clinical Characteristics Among Patients Using INP104 in the United States
    Gokani, T.
    Nguyen, L.
    Vann, R.
    Gutierrez, J.
    Ray, S.
    Aurora, S.
    HEADACHE, 2023, 63 : 157 - 157
  • [50] Demographic and clinical characteristics of patients with metachromatic leukodystrophy in the United Kingdom: Interim results from an observational real-world study
    Jones, Simon
    Davison, James
    Mooney, Peter
    Campbell, Laura
    Baldock, Laura
    Wallington, Mike
    Olaye, Andrew E.
    Chakrapani, Anupam
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S53 - S53
12345